Immunoprevention for High-risk Lung Lesions
Immunoprevention for High-risk Lung Lesions
Recruiting · NCT07284485 · Registry updated 2026-06-08Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Immunoprevention for High-risk Lung Lesions | High-risk Lung Nodules | Recruiting | Phase 2 | 2026-06-08 | NCT07284485 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Cantargia AB | 2 |
| Robert Samstein | 1 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Icahn School of Medicine at Mount Sinai | New York | United States | 342 |